Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ikuei Fujii"'
Autor:
Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Naoko Okayama, Mitsuaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki
Publikováno v:
Liver Cancer (2024)
Background: Patients with hepatitis virus-related hepatocellular carcinoma (viral HCC) are decreasing as hepatitis control improves, but those with non-viral-related HCC (non-viral HCC) are increasing in Japan. No established surveillance system exis
Externí odkaz:
https://doaj.org/article/a0703f6b2ca94c5297d352e3e8d34602
Autor:
Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki
Publikováno v:
Hepatology Communications, Vol 4, Iss 3, Pp 461-470 (2020)
Liquid biopsies are not used in practice for hepatocellular carcinoma (HCC). Epi proColon is the first commercial blood‐based test for colorectal cancer screening based on methylated DNA testing of the septin 9 gene (SEPT9). However, Epi proColon h
Externí odkaz:
https://doaj.org/article/469eeeaaf6aa49a6a95a3763152dae62
Autor:
Yuko Yamaoka, Mai Sasai, Yutaka Suehiro, Shinichi Hashimoto, Atsushi Goto, Naoki Yamamoto, Nobuaki Suzuki, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Toshihiko Matsumoto, Tomomi Hoshida, Michiko Koga, Takeya Tsutsumi, Lay A Lim, Yasuo Matsubara, Shinobu Tomochika, Shin Yoshida, Shoichi Hazama, Hiroshi Yotsuyanagi, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 59:396-403
Background: Although faecal DNA testing of Fusobacterium nucleatum ( Fn) is expected to be useful for colorectal neoplasia detection, there is no standardized quantification method of Fn. We performed this study to establish a possible standardized m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::136c82b7fd26e6420e9a33572c0d2cee
https://doi.org/10.1177/00045632221115559
https://doi.org/10.1177/00045632221115559
Autor:
Yutaka Suehiro, Shigeyuki Suenaga, Yuki Kunimune, Shoko Yada, Kaori Hamamoto, Takanori Tsuyama, Shogo Amano, Hiroto Matsui, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Tomomi Hoshida, Toshihiko Matsumoto, Yuko Fujimoto, Seiji Kaino, Keiko Shinjo, Yutaka Kondo, Isao Sakaida, Taro Takami, Hiroaki Nagano, Takahiro Yamasaki
Publikováno v:
Oncology. 100:674-684
Introduction: We previously developed a novel methylation assay, the combined restriction digital PCR (CORD) assay, consisting of treatment of DNA with methylation-sensitive restriction enzymes and droplet digital PCR. Methods: In this study, we asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69a9dae2eff9b3bbcdb5d8951933f581
https://doi.org/10.1159/000527342
https://doi.org/10.1159/000527342
Autor:
Seiji Kaino, Hiroto Matsui, Shigeyuki Suenaga, Tomomi Hoshida, Ikuei Fujii, Yutaka Suehiro, Taro Takami, Shingo Higaki, Hiroaki Nagano, Yuko Fujimoto, Takahiro Yamasaki, Chieko Suzuki, Toshihiko Matsumoto, Isao Sakaida, Takanori Tsuyama
Publikováno v:
Oncology. 99:234-239
Background: Although serum carbohydrate antigen 19-9 (CA19-9) is widely used as a useful biomarker of pancreatic cancer for monitoring the response to therapy, it is not recommended for screening of early pancreatic cancer because of its limited sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8585fe104a61046cf75fc591f556f47d
https://doi.org/10.1159/000511940
https://doi.org/10.1159/000511940
Autor:
Yutaka Suehiro, Takuya Iwamoto, Masaki Maeda, Yurika Kotoh, Isao Hidaka, Shingo Higaki, Takahiro Yamasaki, Chieko Suzuki, Tsuyoshi Ishikawa, Hiroaki Nagano, Issei Saeki, Taro Takami, Toshihiko Matsumoto, Isao Sakaida, Tomomi Hoshida, Yukio Tokumitsu, Yoshitaro Shindo, Ikuei Fujii
Publikováno v:
Hepatology Communications, Vol 4, Iss 3, Pp 461-470 (2020)
Liquid biopsies are not used in practice for hepatocellular carcinoma (HCC). Epi proColon is the first commercial blood‐based test for colorectal cancer screening based on methylated DNA testing of the septin 9 gene (SEPT9). However, Epi proColon h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b426301f7d22412b37d1f1c973e03900
https://doi.org/10.1002/hep4.1469
https://doi.org/10.1002/hep4.1469
Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer
Autor:
Taro Takami, Tomomi Hoshida, Takahiro Yamasaki, Isao Sakaida, Toshihiko Matsumoto, Issei Saeki, Hiroyuki Fujimura, Atsushi Goto, Chieko Suzuki, Kouichi Hamabe, Takuya Shuto, Shingo Higaki, Eizaburou Hideura, Takeshi Okamoto, Ikuei Fujii, Yutaka Suehiro, Shunsuke Ito, Jun Nishikawa
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 789 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 789 (2020)
The main modalities for gastric cancer screening are limited to upper gastrointestinal endoscopy and contrast radiography. The former is invasive, and the latter has high false-negative rates. Thus, alternative diagnostic strategies are required. One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48933e0e734f85e15ca8fd0a31d708a9
https://pubmed.ncbi.nlm.nih.gov/32224873
https://pubmed.ncbi.nlm.nih.gov/32224873
Autor:
Yutaka Suehiro, Shingo Higaki, Tomomi Hoshida, Isao Sakaida, Toshihiko Matsumoto, Ikuei Fujii, Taro Takami, Yuko Yamaoka, Takahiro Yamasaki, Chieko Suzuki, Shinichi Hashimoto
Publikováno v:
Oncotarget
Although methylated TWIST1 is a biomarker of colorectal neoplasia, its detection from serum samples is very difficult by conventional bisulfite-based methylation assays. Therefore, we have developed a new methylation assay that enables counting of ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293eae52172d38c8e2aef16f72556c5c
http://europepmc.org/articles/PMC5908299
http://europepmc.org/articles/PMC5908299
Autor:
Yurika, Kotoh, Yutaka, Suehiro, Issei, Saeki, Tomomi, Hoshida, Masaki, Maeda, Takuya, Iwamoto, Toshihiko, Matsumoto, Isao, Hidaka, Tsuyoshi, Ishikawa, Taro, Takami, Shingo, Higaki, Ikuei, Fujii, Chieko, Suzuki, Yoshitaro, Shindo, Yukio, Tokumitsu, Hiroaki, Nagano, Isao, Sakaida, Takahiro, Yamasaki
Publikováno v:
Hepatology Communications
Liquid biopsies are not used in practice for hepatocellular carcinoma (HCC). Epi proColon is the first commercial blood‐based test for colorectal cancer screening based on methylated DNA testing of the septin 9 gene (SEPT9). However, Epi proColon h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c75d19c97e8eabc4ee415d8d25f239f
https://pubmed.ncbi.nlm.nih.gov/32140662
https://pubmed.ncbi.nlm.nih.gov/32140662
Autor:
Takahiro Yamasaki, Toshihiko Matsumoto, Takeya Tsutsumi, Chieko Suzuki, Atsushi Goto, Hiroaki Nagano, Michiko Koga, Nobuaki Suzuki, Ikuei Fujii, Hiroshi Yotsuyanagi, Yutaka Suehiro, Isao Sakaida, Naoki Yamamoto, Shinichi Hashimoto, Shin Yoshida, Yasuo Matsubara, Tomomi Hoshida, Shingo Higaki, Lay Ahyoung Lim, Yuko Yamaoka, Shoichi Hazama, Taro Takami
Publikováno v:
Clinical and Translational Gastroenterology
Introduction We have reported previously that fecal DNA testing of TWIST1 methylation in combination with the fecal immunochemical test for hemoglobin (FIT) (combination test) is useful for colorectal neoplasia screening. In this study, using larger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36101c00a422ee2c52af1abd8c2a076b
https://doi.org/10.14309/ctg.0000000000000176
https://doi.org/10.14309/ctg.0000000000000176